Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anavex Life Sciences

7.78
+0.06000.78%
Post-market: 7.77-0.0105-0.13%16:57 EDT
Volume:579.06K
Turnover:4.50M
Market Cap:664.19M
PE:-14.00
High:7.85
Open:7.74
Low:7.66
Close:7.72
Loading ...

Largest borrow rate increases among liquid names

TIPRANKS
·
03 Jun

Optimistic Buy Rating for Anavex Life Sciences Amid Anticipated EMA Feedback and Strategic Preparations

TIPRANKS
·
17 May

Stock Track | Anavex Life Sciences Plummets 5.15% Despite Beating Q2 Earnings Estimates

Stock Track
·
13 May

Anavex Life Sciences Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Anavex Life Sciences Q2 EPS $(0.13) Beats $(0.15) Estimate

Benzinga
·
13 May

Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update

THOMSON REUTERS
·
13 May

Anavex Life Sciences Corp expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
09 May

Anavex Life Sciences' Schizophrenia Clinical Study Completes Enrollment

MT Newswires Live
·
01 May

Anavex Life Sciences Corp - Top Line Data Expected in Second Half of 2025

THOMSON REUTERS
·
01 May

Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of Anavex®3-71 for the Treatment of Schizophrenia

THOMSON REUTERS
·
01 May

Anavex Life Sciences Corp - Phase 2 Study Part a and B Fully Enrolled

THOMSON REUTERS
·
01 May

Anavex Life Sciences to Participate in The Citizens Life Sciences Conference

GlobeNewswire
·
30 Apr

Anavex Life Sciences Announces Appointment of DR. Audrey Gabelle, Md, Phd to the Scientific Advisory Board

THOMSON REUTERS
·
23 Apr

Press Release: Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board

Dow Jones
·
23 Apr

Anavex Life Sciences Corp (AVXL) Q1 2025 Earnings Call Highlights: Promising Alzheimer's Data ...

GuruFocus.com
·
22 Apr

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

GlobeNewswire
·
21 Apr

High Growth Tech Stocks To Watch In The US Market

Simply Wall St.
·
08 Apr

Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years

Benzinga
·
08 Apr

Anavex Life Sciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
07 Apr

Anavex Life Sciences Price Target Maintained With a $42.00/Share by HC Wainwright & Co.

Dow Jones
·
07 Apr